← Open Payments lookup

PATRICIA DEHOF: Open Payments

NPI 1376611400 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$450 in 20 payments from 12 companies in 2025. Trend: 2023 $442 · 2024 $145 · 2025 $450

Food & beverage: $450
CompanyPaymentsAmount
Astellas Pharma US Inc3$79
MAYNE PHARMA COMMERCIAL LLC3$66
Sumitomo Pharma America, Inc.3$61
Daiichi Sankyo Inc.2$57
SHIELD THERAPEUTICS INC2$54
Merck Sharp & Dohme LLC1$23
Amgen Inc.1$21
Sage Therapeutics, LLC1$20
Supernus Pharmaceuticals, Inc.1$20
CooperSurgical, Inc.1$18

Products named: Veozah, INJECTAFER, ACCRUFER, GEMTESA, GARDASIL 9, EVENITY, MYFEMBREE, ZURZUVAE.

Industry payments across MD — which companies pay providers there.